Related Experiment Video
Updated: Jun 2, 2026
07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Magnesium for neuroprotection in birth asphyxia
Geeta Gathwala1, Atul Khera, Jagjit Singh
1Department of Pediatrics, Neonatal Services Division, Pt. B.D. Sharma Post Graduate Institute of Medical Sciences, University of Health Sciences, Rohtak, Haryana, India.
Journal of Pediatric Neurosciences
|May 12, 2011
Summary
Magnesium sulfate shows promise in protecting newborns from brain injury due to birth asphyxia. This study found beneficial effects, suggesting its potential as a neuroprotective agent in neonates.
Area of Science:
- Neuroscience
- Neonatal Medicine
- Pharmacology
Background:
- Magnesium ions regulate N-methyl-D-aspartate (NMDA) receptors.
- NMDA receptor overactivation can cause brain injury during asphyxia.
- Magnesium's potential neuroprotective role in birth asphyxia warrants investigation.
Purpose of the Study:
- To evaluate the neuroprotective effects of magnesium sulfate in term neonates experiencing severe birth asphyxia.
Main Methods:
- Forty neonates with severe birth asphyxia were randomized into a study group (magnesium sulfate) and a control group.
- Magnesium sulfate was administered at specific doses post-birth.
- Cranial CT scans, electroencephalography (EEG), and Denver II developmental assessments were conducted.
Main Results:
- Magnesium sulfate administration was associated with reduced EEG abnormalities (31.25% vs. 43.75%) and CT scan abnormalities (37.5% vs. 62.5%) compared to the control group.
- Fewer infants in the magnesium group had abnormal or suspect developmental assessments at 6 months (3 vs. 5).
- Two deaths occurred in each group due to severe hypoxic ischemic encephalopathy.
Conclusions:
- Magnesium sulfate is well-tolerated in neonates with severe birth asphyxia.
- The study suggests potential beneficial effects of magnesium sulfate in this population.
- Further research, including large multicenter trials, is recommended to confirm these findings.
